Keywords
Burkholderia pseu-
How to Cite
Abstract
Melioidosis – a Deadly Disease Emerging Threat Beyond Tropics. Emerging of Global Risk Knap J.P. 1 1 Warsaw’s Medical University, Department of Epidemiology and Biostatistics, Warsaw, Poland Przedstawiono kliniczną, epidemiologiczną i etiologiczną w kontekście ewolucyjnym analizę melioidozy (choroby Whitmore’a), bakteryjnej saprozoonozy wywoływanej przez Gram-pałeczkę Burkholderia pseudomallei, blisko spokrewnioną z pałeczką nosacizny (B. mallei). Omówiono niepokojące cechy melioidozy jako choroby stanowiącej światowe zagrożenie (emerging infectious disease) z racji jej tendencji do globalnego szerzenia się, cech klinicznych (ciężkość przebiegu, wielkie zróżnicowanie objawów, antybiotykooporność, zdolność latencji) i wielkiej plastyczności zarazka, którego rezerwuarem jest środowisko (gleba, woda), zdolnego do przeżycia w skrajnie niekorzystnych warunkach środowiskowych.
References
Knap J.P.: Szczególnie niebezpieczne choroby infekcyjne i czynniki alarmowe – przywlekane do Polski. Próba anali- zy. W: Konieczny J., red. Bezpieczeństwo epidemiologiczne. Postępy metodologii badań. Poznań: Garmond; 2013. 18-33.
Galeas-Pena M., Morici L.D.: Vaccine development against melioidosis. W: Christodoulides M., red. Vaccines for neglec- ted pathogens: strateges, achivements and challenges. Fo- cus on leprosy, leishmaniasis, melioidosis and tuberculosis. New York: Springer; 2023. 327-344.
Bzdyl N.M., Moran C.L., Bendo J. i in.: Pathogenicity and virulence of Burkholderia pseudomallei. Virulence 2021; 213(1): 1945-1965.
Zanetti F., de Luca G., Stampi S.: Recovery of Burkholde- ria pseudomallei and B. cepacia from drinking water. Intern J Food Microbiol 2000: 59: 67-72.
Clayton A.J., Lisella R.S., Martin D.G.: Melioidosis: a serolo- gical survey in military personnel. Milit Med 1973; 138: 24-26.
Currie B.J., Smith Vaughan H., Golledge C. i in: Pseudo- monas pseudomallei isolates collected over 25 years from a non-tropical endemic focus show clonality on the basis of ribotyping. Epidemiol Infect 1994; 113: 307-312.
Currie B.J.: Burkholderia pseudomallei and Burkholderia mallei: Melioidosis and glanders. W: Mandell D., Bennett J.E., Dolin R., red. Bennett’s Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone Elsvier; 2010. 2869-2879.
Dance D.A.B.: An account of a glanders-like disease occur- ring in Rangoon. J Hyg 2005; 13: 1-34.
Trinh T.T., Nguyen L.D.N., Nguyen T.V. i in.: Melioidosis in Vietnam: recently improved recognition but still an ucertain disease burden after a almost a century of report. Trop Med Infect Dis 2018; 2. doi:10.3390/tropicalmed.3020039.
Savalkoel L., Dance D.A.: Alfred Whitmore and the discovery of melioidosis. Emerg Infect Dis 2024; 30: 4.
Wiersinga W.I., Currie B.J., Peacock S.J.: Melioidosis. New Engl J Med 2012; 367: 1035-1044.
Whitmore A., Krishnaswami C.S.: An account of the disco- very of a hitherto undescribed infective disease occurring among the population of Rangoon. Indian Med Gaz 1912; 47: 262-267.
Whitmore A.: An account of a glanders-like disease occurring in Rangoon. J Hyg 1913; 13(1): 1-34.
Knapp H.H.G.: Morphine injector’s septicaemia (Whitemo- re’s disease). Indian Med Gaz. 1915; 50: 287-288.
Krishnaswami C.S.: Morphia injector’s septicaemia. Indian Medical Gazette 1917; 52: 296-299.
Dance D.A.B.: Melioidosis. W: Cook G.C., Zumla A.I., red. Manson’s tropical diseases. London, N. York, Oxford: Saun- ders Elsevier; 2009. 1127-1131.
Ashdown L.R.: An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pa- thology 1979; 11(2): 293-297.
Gasslep J., Chatfield M.D., Permana B. i in.: The genomic epidemiology of clinical Burkholderia pseudomallei isolates in North Queensland, Australia. Pathogens 2024; 13(7): 584.
Inglis T.J.: Melioidosis in Australia. Microbiology Australia 2021; 42: 96-99.
Philips E.D., Garcia E.C.: Burkholderia pseudomallei. Trends Microbiol 2024; 32(1): 105-106.
Thomas A.D., Forbes Faulkner J., Parker M.: Isolation of Burkholderia pseudomallei from day layers at different depth. Amer J Epid 1979; 110: 515-521.
Chawaprecha A., Holden M.T.G., Vekhala M. i in.: Global and regional dissemination and evolution of Burkholderia pseudomallei. Nt Microbiol 2017; 2: 162-163.
Rachlin A., Mayo M., Webb J.R. i in.: Whole genome sequ- encing an urban melioidosis hat spot reveales a fine – scale population structure and localized spatial clustering in the environment. Scientific Reports 2020; 10: 5443.
Currie B.J., Mayo M., Ward L.M. i in.: The Darwin Prospec- tive Melioidosis Study: a 30-year prospective observational investigations. Lancet Infectious Diseases 2021; 21(12): P1737-P1746.
Limmathurotsakul D., Golding N., Dance D.A.B. i in.: Pre- dicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nature Microbiology 2016; 1(1): 15.
Limmathurotsakul D., Daily F., Bory S.: Melioidosis: the ha- zard of incomplete peer-review. PLoS Negl Trop Dis 2019; 13(3): e0007123.
Norman F.F., Chen L.L.: Travel – associated melioidosis: a narrative review. J Travel Med 2023;30(3). doi: 10.1093.
Fong J.H., Pillai N.K., Jahan N.K.: Incidence, case fatality rates and epidemiology of melioidosis worldwid: a review pa- per. Open Access Library Journal 2021; 8(6): 1-20.
Mc Arthur D.B.: Emerging infection diseases. Nurs Clin North America 2019; 54(2): 297-311.
White N.J.: Melioidosis and glanders. W: Magill A.J., Ryan E.T., Hill D.R., Solomon T., red. Hunter’s Tropical Medicine and Emerging Infectious Diseases. London, New York, Oxford: Elsevier Saunders. 580-583.
Wiersinga W.J., Virk H.S., TorresA.G. i in.: Melioidosis. Re- views Disease Primers 2018: 4: 17107.
Dance D.A.B.: Melioidosis: the tip of iceberg? Clin Microbiol Rev 1991; 4: 52-60.
Savalkoel L., Dance R.B., Currie B.J.: A call to action: time to recognize melioidosis a neglected tropical disease. Lancet Infect Dis 2022; 22(6): e1682.
Sing Virrk H., Nic Fogapta g.H., Dance D.A.B.: Glandes & melioidosis: same same, but different. W: Sing A., red. Zo- onoses: infections affecting human and animals. New York: Springer; 2020. 1331-1375.
Cheng A.C., Currie B.J.: Melioidosis: epidemiology, patho- physiology, and management. Clin Microbiol Rev 2006; 18: 383-416.
Gliński Z., Kostro K.: Nosacizna – groźna choroba i zagro- żenie bioterrorystyczne. Życie Weter 2012; 87(5): 389-393.
Lee S.H., Nathan S.: Burkholderia pseudomallei: an upda- te of disease, virulence and host interaction. Malaysian App Biol 2013; 42(1): 1-14.
Song H., Hwang J., Yi H. i in.: The early stage of Bacterial Genome – Reduction in the Host. PLoS Pathogens 2010; 6(5): e1000922.
Badran S., Pedersen T.J., Roed C. i in.: Imported melioidosis in Danish travelers: a diagnostic challenge. Scand J Infect Dis 2010; 42(6-7): 445-449. J. P. Knap, Melioidoza – szczególnie niebezpieczna choroba nie tylko tropików. Powstawanie globalnego...43
Cheng A.C., Wuthekanun V., Limmathurotsakul D. i in.: Inten- sity of exposure and incidence of melioidosis Thai children. Trans Roy Soc Trop Med Hyg 2008; 102(supl. 1): 537-539.
Chowthury S., Barai I., Afroze S. i in.: The epidemiology of melioidosis and its association with diabetes mellitus: a sys- tematic review and meta-analysis. Pathogens 2022; 11(2): 149.
Czerkasskij B.L., Kudrjawcew A.E.: Melioidoz. W: Pokrowskij W.I., red. Rukowodstwo po zoonozam. Leningrad: Medicina; 1983. 184-189.
Weber D.R., Douglas L.E., Brundage W.G. i in.: Acute va- rieties of melioidosis occurring in US soldiers in Vietnam. Am J Med 1969; 46: 234-244.
Kierznikowicz B., Knap J., red. Służba Zdrowia Wojska Pol- skiego w misjach pokojowych. Warszawa: euroStar; 2001.
Ngauy V., Lemeshev Y., Sadkowski L. i in.: Cutaneous melio- idosis in a man who was taken as a prisoner of war by Japa- nese Turing World War II. J Clin Microbiol 2005; 43: 970-972.
Mackowiak P.A., Smith J.W.: Septicemic melioidosis. Occur- rence following acute influenza a six years after exposure in Vietnam. JAMA 1978; 240: 764.
Mays E.E., Rickets E.A.: Recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure. Chest 1975; 68: 261.
Department of Health and Human Services: Possession, Use and transfer of select agents and toxins. biennal review. Federal Register 2012; 77(194): 2012-2438.
Lasocki K., Roszkowiak A.: Nosacizna i melioidoza – zapo- mniane a ciągle groźne choroby. W: Piątek Z., Zdrojewski A., red. Służby mundurowe w epidemiologii. Warszawa: SRWO; 2012. 143-149.
Michalski M., Knap J., Bielawska-Drózd A. i in.: Lesson le- arned – fom 2001 200–2021 – from the bioterrorosm to the pandemic era. Ann Agricult Environm Med 2022; 29(1); 1-11.
Peacock S.J., Schweizer H.P., Dance D.A. i in: Management of accidental laboratory exposure to Burkholderia pseudomal- lei and Burkholderia mallei. Emerg Infect Dis 2008; 14: e2.
Chaowagul W., White N.J., Dance D.A.B. i in.: Melioidosis: a major cause of community-acquired septicemia in northe- astern Thailand. J Infect Dis 1989; 159: 890-899.
Badten A.J., Torre A.G.: Burkholderia pseudomallei Com- plex. Subunit and glyconjugate vaccines and their potential- to elicit cross-protection to Burkholderia Cepacia Complex. Vaccines 2024; 12(3): 313.
Johnson M.M., Ainslie K.M.: Vaccines for the prevention on melioidosis and glanders. Curr Ther Trop Med Rep 2017; 4(3): 136-145.
Tulius M.V., Back A., Maslesa-Galić S. i in.: LVSDeltacapB- -vectored multiantigenic melioidosis vaccine protect against lethal respiratory Burkholderia pseudomallei challenge in hi- ghly sensitivity BALB/C mice. mBio 2024: 15(4): e.0018624.
Anusz Z.: Zapobieganie i zwalczanie zawodowych chorób odzwierzęcych. Olsztyn: Wyd. Art; 1995. 78-82.
Godoy D., Randle G., Simpson A.J. i in.: Multilocus sequen- ce typing and evolutionary relationship among the causative agents of melioidosis and glanders, Burkholderia pseudo- mallei and Burkholderia mallei. J Clin Microbiol 2003; 41: 2068-2079.
Losada A., Ronning C.M., de Shazer D. i in.: Continuing evo- lution of Burkholderia mallei through genome reduction and large-scale rearrangement. Genome Biol Evol 2010; 2: 102- 116.
Gliński Z., Kostro K.: Nosacizna – groźna choroba i zagro- żenie bioterrorystyczne. Życie Weter 2012; 87(5): 389-393.
Clayton A.J., Lisella R.S., Martin D.G.: Melioidosis: a sero- logical survey in military personnel. Milit. Med. 1973; 138: 24-26.
Dance D.A.B.: Melioidosis: the tip of iceberg? Clin Microbiol Rev 1991; 4: 52-60.
Howe C., Sampath A., Spotnitz M.: The Pseudomallei Group: a review. J Infect Dis 1971; 124(6): 598-606.
Inglis T.J.: Melioidosis in Australia. Microbiology Australia 2021; 42: 96-99.
Kierznikowicz B., Knap J., red.: Służba Zdrowia Wojska Pol- skiego w misjach pokojowych. Warszawa: euroStar; 2001.
Michalski M., Knap J., Bielawska-Drózd A., Bartoszcze M. i in.: Lesson learned 2001–2021 – from the bioterrorosm to the pandemic era. Ann. Agricult Environm Med 2022; 29(1): 1-11.
Ngauy V., Lemeshev Y., Sadkowski L. i in.: Cutaneous melio- idosis in a man who was taken as a prisoner of war by Japa- nese Turing World War II. J Clin Microbiol 2005; 43: 970-972.
Owen S.J., Batzloff M., Chehrehasa F. i in.: Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis. J Infect Dis 2009;199 (42): 1761-1700.
Philips E.D., Garcia E.C.: Burkholderia pseudomallei. Trends Microbiol 2024; 32(1): 105-106.
Savalkoel L., Dance R.B., Currie B.J.: A call to action: time to recognize melioidosis a neglected tropical disease. Lancet Infect Dis 2022; 22(6): e1682.
Sing Virrk H., Nic Fogapta G.H., Dance D.A.B.: Glandes & melioidosis: same same, but different. W: Andreas Sing A., (red.): Zoonoses: infections affecting human and animals. New York: Springer; 2020. 1331-1375
St. John J.A., Ekberg J.A., Dandos J. i in.: Burkholderia pseudomallei penetrates the brain via destruction of the ol- factory and trigeminal nerves: implications for the pathogene- sis of neurological melioidosis. MmBio 2014; 15 (5): e00025.
Weber D.R., Douglas L.E., Brundage W.G. i in.: Acute va- rieties of melioidosis occurring in US soldiers in Vietnam. Am J Med 196; 46: 234-244.
Wiersinga W.I., Currie B.J., Peacock S.J.: Melioidosis. New Engl J Med 2012; 367: 1035-1044.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2024 Review of Medical Practice